29 Double blind, placebo controlled study of efficacy and safety of rynatan to treat allergic rhinitis

Journal of Allergy and Clinical Immunology ◽

10.1016/0091-6749(88)90266-7 ◽

1988 ◽

Vol 81 (1) ◽

pp. 176

Author(s):

J.M. Weiler ◽

J.M. Glassman ◽

J.P. Sovka

Keyword(s):

Allergic Rhinitis ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis☆☆☆

Journal of Allergy and Clinical Immunology ◽

10.1016/s0091-6749(99)70070-9 ◽

1999 ◽

Vol 104 (5) ◽

pp. 927-933 ◽

Author(s):

Peter H. Howarth ◽

Martin A. Stern ◽

Larry Roi ◽

Robert Reynolds ◽

Jean Bousquet

Keyword(s):

Allergic Rhinitis ◽

Seasonal Allergic Rhinitis ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and Safety of Ebastine 20 mg Compared to Loratadine 10 mg Once Daily in the Treatment of Seasonal Allergic Rhinitis: A Randomized, Double-Blind, Placebo-Controlled Study

International Archives of Allergy and Immunology ◽

10.1159/000077357 ◽

2004 ◽

Vol 133 (4) ◽

pp. 371-379 ◽

Author(s):

P. Ratner ◽

F. Hampel Jr. ◽

J. van Bavel ◽

W. Howland, III

Keyword(s):

Allergic Rhinitis ◽

Seasonal Allergic Rhinitis ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of triamcinolone acetonide aqueous nasal spray in children aged 2 to 5 years with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled study with an open-label extension

Annals of Allergy Asthma & Immunology ◽

10.1016/s1081-1206(10)60340-7 ◽

2009 ◽

Vol 102 (4) ◽

pp. 339-347 ◽

Author(s):

Steven Weinstein ◽

Paul Qaqundah ◽

George Georges ◽

Anjuli Nayak

Keyword(s):

Allergic Rhinitis ◽

Triamcinolone Acetonide ◽

Nasal Spray ◽

Controlled Study ◽

Efficacy And Safety ◽

Perennial Allergic Rhinitis ◽

Double Blind ◽

Double Blind Placebo ◽

Open Label Extension

Download Full-text

A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Ebastine 20 mg Once Daily Given with and without Food in the Treatment of Seasonal Allergic Rhinitis

CrossRef Listing of Deleted DOIs ◽

10.1177/009127002401382696 ◽

2002 ◽

Vol 42 (10) ◽

pp. 1097-1104 ◽

Author(s):

F. Hampel Jr. ◽

M. Gillen ◽

S.S. Rohatagi ◽

J. Lim ◽

G. Georges

Keyword(s):

Allergic Rhinitis ◽

Seasonal Allergic Rhinitis ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Mo1540 THE EFFICACY AND SAFETY OF GCWB104 (FLOS LONICERA EXTRACT) IN FUNCTIONAL DYSPEPSIA: A SINGLE-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

Gastroenterology ◽

10.1016/s0016-5085(20)32906-1 ◽

2020 ◽

Vol 158 (6) ◽

pp. S-887-S-888

Author(s):

Nayoung Kim ◽

Yonghoon Choi ◽

Dong Ho Lee

Keyword(s):

Functional Dyspepsia ◽

Controlled Study ◽

Efficacy And Safety ◽

Single Center ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725732407.793547378 ◽

2018 ◽

Author(s):

Maria Laura Bertolaccini

Keyword(s):

Systemic Lupus Erythematosus ◽

Monoclonal Antibody ◽

Lupus Erythematosus ◽

Phase Iii ◽

Controlled Study ◽

Efficacy And Safety ◽

Systemic Lupus ◽

Double Blind ◽

Double Blind Placebo ◽

B Cell Activating Factor

Download Full-text

Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of AS-013, a Prostaglandin E1Prodrug, in Patients With Intermittent Claudication

Circulation ◽

10.1161/01.cir.95.9.2298 ◽

1997 ◽

Vol 95 (9) ◽

pp. 2298-2302 ◽

Author(s):

J.J.F. Belch ◽

P.R.F. Bell ◽

D. Creissen ◽

J.A. Dormandy ◽

R.C. Kester ◽

...

Keyword(s):

Intermittent Claudication ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Statement of Retraction: Efficacy and safety of vortioxetine for the treatment of major depressive disorder: a randomised double-blind placebo-controlled study

International Journal of Psychiatry in Clinical Practice ◽

10.1080/13651501.2021.1950437 ◽

2021 ◽

pp. 1-1

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Controlled Study ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

The efficacy and safety of dupilumab in Chinese patients with moderate‐to‐severe atopic dermatitis: a randomized, double‐blind, placebo‐controlled study

British Journal of Dermatology ◽

10.1111/bjd.20690 ◽

2021 ◽

Author(s):

Y. Zhao ◽

L. Wu ◽

Q. Lu ◽

X. Gao ◽

X. Zhu ◽

...

Keyword(s):

Atopic Dermatitis ◽

Chinese Patients ◽

Controlled Study ◽

Severe Atopic Dermatitis ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis

Arthritis & Rheumatology ◽

10.1002/art.39722 ◽

2016 ◽

Vol 68 (9) ◽

pp. 2174-2183 ◽

Author(s):

Brad H. Rovin ◽

Ronald F. van Vollenhoven ◽

Cynthia Aranow ◽

Carrie Wagner ◽

Robert Gordon ◽

...

Keyword(s):

Lupus Nephritis ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Active Lupus Nephritis ◽

Download Full-text